Skip to main content
Livermore
Livermore
ZHEN

Squarepoint Ops LLC

SEC CIK
0001642575
Latest filing
Aug 14, 2026

CTMX holding history

CytomX Therapeutics, Inc. in every 13F filed by Squarepoint Ops LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

CTMX overviewAll 13F holders of CTMXFull Q2 2026 holdings

Shares (Q2 2026)
112,152
Value
$420.6K
% of portfolio
<0.1%
Quarters held
18
Since Q1 2021
Holdings of CTMX by Squarepoint Ops LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026112,152$420.6K<0.1%−129,063−53.5%ReducedHolders
Q1 2026241,215$1.13M<0.1%+191,318+383.4%AddedHolders
Q4 202549,897$212.6K<0.1%+2,169+4.5%AddedHolders
Q3 202547,728$152.3K<0.1%−1,664−3.4%ReducedHolders
Q2 202549,392$112.1K<0.1%+49,392NewHolders
Q3 20240$00.0%−198,840−100.0%Sold outHolders
Q2 2024198,840$242.6K<0.1%−11,311−5.4%ReducedHolders
Q1 2024210,151$458.1K<0.1%+59,618+39.6%AddedHolders
Q4 2023150,533$233.3K<0.1%−23,092−13.3%ReducedHolders
Q3 2023173,625$224.0K<0.1%−10,869−5.9%ReducedHolders
Q2 2023184,494$317.3K<0.1%+135,638+277.6%AddedHolders
Q1 202348,856$73.8K<0.1%+48,856NewHolders
Q4 20220$00.0%−10,523−100.0%Sold outHolders
Q3 202210,523$15.0K<0.1%−36,160−77.5%ReducedHolders
Q2 202246,683$85.0K<0.1%−60,078−56.3%ReducedHolders
Q1 2022106,761$285.0K<0.1%+68,812+181.3%AddedHolders
Q4 202137,949$164.0K<0.1%−1,769−4.5%ReducedHolders
Q3 202139,718$202.0K<0.1%−708,569−94.7%ReducedHolders
Q2 2021748,287$4.74M<0.1%+666,574+815.8%AddedHolders
Q1 202181,713$632.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.